Elsevier

Experimental Cell Research

Volume 312, Issue 12, 15 July 2006, Pages 2379-2393
Experimental Cell Research

Research Article
MEGAP impedes cell migration via regulating actin and microtubule dynamics and focal complex formation

https://doi.org/10.1016/j.yexcr.2006.04.001Get rights and content

Abstract

Over the past several years, it has become clear that the Rho family of GTPases plays an important role in various aspects of neuronal development including cytoskeleton dynamics and cell adhesion processes. We have analysed the role of MEGAP, a GTPase-activating protein that acts towards Rac1 and Cdc42 in vitro and in vivo, with respect to its putative regulation of cytoskeleton dynamics and cell migration. To investigate the effects of MEGAP on these cellular processes, we have established an inducible cell culture model consisting of a stably transfected neuroblastoma SHSY-5Y cell line that endogenously expresses MEGAP albeit at low levels. We can show that the induced expression of MEGAP leads to the loss of filopodia and lamellipodia protrusions, whereas constitutively activated Rac1 and Cdc42 can rescue the formation of these structures. We have also established quantitative assays for evaluating actin dynamics and cellular migration. By time-lapse microscopy, we show that induced MEGAP expression reduces cell migration by 3.8-fold and protrusion formation by 9-fold. MEGAP expressing cells also showed impeded microtubule dynamics as demonstrated in the TC-7 3x-GFP epithelial kidney cells. In contrast to the wild type, overexpression of MEGAP harbouring an artificially introduced missense mutation R542I within the functionally important GAP domain did not exert a visible effect on actin and microtubule cytoskeleton remodelling. These data suggest that MEGAP negatively regulates cell migration by perturbing the actin and microtubule cytoskeleton and by hindering the formation of focal complexes.

Introduction

Cell migration plays a central role in a variety of fundamental processes including embryogenesis, immune response, tissue repair, tumorigenesis, as well as congenital developmental brain defects. Cell migration is a rather complex process, requiring the coordinated activity of the actin and microtubule cytoskeleton and the adhesion system. It can be described as a multistep cycle comprising of the extension of protrusions at the cell front, formation of stable attachments near the protrusions, translocation of the cell body forward, and release of adhesions and retraction at the rear end of the cell [1]. The membrane extension consists of both lamellipodia and filopodia, and it takes place primarily around the cell front. Lamellipodia are broad, veil-like structures, whereas filopodia are thin, cylindrical, needle-like projections. The formation of these highly dynamic protrusive structures at the leading edge of moving cells requires force generated by actin polymerisation. Actin monomers polymerise only onto the existing barbed end of the actin array, so that the actin filaments are elongated towards the cell periphery [2]. The formation of a protrusion initiates the migration cycle process, but in order for the cell to move, the protrusions have to be stabilised to the substratum. These adhesion sites serve as traction points for impellent forces that push the cell moving forward. Migration needs the continuous coordinated formation and disassembly of adhesions [3].

The concerted interaction of microtubules and actin is essential for maintaining cell motility. Dynamic instability of microtubules is required to keep the polarised actin cytoskeleton-based protrusions in the cell-leading edge [4], [5]. Microtubules promote the release of substrate adhesions by targeting them at the cell front and rear with different frequencies [6]. This multistep migration process is tightly controlled by the regulated interaction of numerous proteins and the activation of specific signalling pathways. Among intracellular signalling molecules, small GTP-binding proteins of the Rho subfamily, in particular Cdc42, Rac1, and RhoA, have been shown to play important roles in the control of this process through regulating actin dynamics, microtubule cytoskeleton, and the assembly of integrin-mediated focal complexes [7], [8], [9], [10]. We have found that haploinsufficiency of a RhoGAP gene, MEGAP, is associated with mental retardation in several patients. MEGAP, also known as WRP [11], represents a functional GTPase-activating (GAP) protein as demonstrated by an in vitro GAP assay leading to an inactivation of the Rac1 and Cdc42-mediated signal transduction processes [12]. To study the presumed role of MEGAP in actin organisation and cell migration, we have established an inducible cell model system that expresses MEGAP under the control of a doxycycline-inducible promoter.

The ability of Rho family GTPases in signalling events is dependent on the fraction of GTP/GDP-bound forms in the cell. The switch of GTPases between active GTP-bound states and inactive GDP-bound states is regulated by two divergent factors: guanine nucleotide exchange factors (GEFs) that enhance the exchange of GDP for GTP [13], [14] and the GTPase-activating proteins (GAPs) that augment hydrolysis of bound GTP [15]. In addition, GTPases are regulated by guanine nucleotide dissociation inhibitors, which are thought to block the GTPase cycle by sequestering the GDP-bound form [16].

Even though a substantial amount of work has been focused on the characterisation of various GAPs [15], little is known to quantitatively define the function of a GAP regarding the direct influence on cytoskeleton dynamics in vivo. We report here the effect of MEGAP towards cellular morphology and cell migration in SHMEGAP cells, which are derived from a SHSY-5Y neuroblastoma line. We demonstrate that expression of MEGAP can downregulate Cdc42 and Rac1 activity and attenuate random migration of the cells by impairing actin and microtubule dynamics, formation of protrusions, and focal complexes.

Section snippets

Reagents, antibodies, DNA constructs, and cell lines

DMEM low glucose, HEPES medium, and tetracycline-free fetal calf serum for cell culture were from PAA Laboratories (Linz, Austria). Fugene 6 (Roche Diagnostics, Mannheim, Germany) and Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) were applied for transfection of SHSY-5Y cell line and the line SHMEGAP (derived from SHSY-5Y, stably transfected with MEGAP) with a DNA: reagent ratio of 1:6 and 4:10, respectively. Both blasticidin and zeocin from Invitrogen were used for MEGAP-positive clone

Inducible expression of MEGAP in SHMEGAP cells reduces GTP-bound Cdc42 and Rac1

We have previously reported that MEGAP is predominantly expressed in fetal and adult brain tissues and that the GAP domain of MEGAP acts towards the GTPases Rac1 and Cdc42 but not RhoA in vitro [12]. Rac1 and Cdc42 have been implicated in the regulation of cytoskeleton-related cellular processes such as cell polarisation, migration, neurite outgrowth, and phagocytosis [17], [18]. To evaluate the function of MEGAP in the control of these GTPases and to analyse the cytoskeleton modulation

Discussion

Over the past several years, it has become clear that the Rho family of GTPases plays an important role in different aspects of neuronal development and neuronal morphogenesis including neurite outgrowth and differentiation, axonal pathfinding, and dendrite spine formation and maintenance. Among the non-specific mental retardation genes (including MEGAP) identified so far, about half belong to Rho-linked genes involved in Rho-GTPase [29]. Patients with syndromic and nonsyndromic mental

Acknowledgments

Y. Y. and V. E. were supported by the BMBF grant GS0117 and GS0167 to G. R.; M. M. by a joint collaboration Hamamatsu/DKFZ (project PA 11631).

References (51)

  • R.O. Hynes

    Integrins: bidirectional, allosteric signaling machines

    Cell

    (2002)
  • G.J. Ramakers

    Rho proteins, mental retardation and the cellular basis of cognition

    Trends Neurosci.

    (2002)
  • J. Peck et al.

    Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships

    FEBS Lett.

    (2002)
  • N. Lamarche-Vane et al.

    CdGAP, a novel proline-rich GTPase-activating protein for Cdc42 and Rac

    J. Biol. Chem.

    (1998)
  • I. Lavelin et al.

    Characterization of a novel GTPase-activating protein associated with focal adhesions and the actin cytoskeleton

    J. Biol. Chem.

    (2005)
  • B.M. Gumbiner

    Proteins associated with the cytoplasmic surface of adhesion molecule

    Neuron

    (1993)
  • B.M. Gumbiner

    Cell adhesion: the molecular basis of tissue architecture and morphogenesis

    Cell

    (1996)
  • K.A. DeMali et al.

    Integrin signaling to the actin cytoskeleton

    Curr. Opin. Cell Biol.

    (2003)
  • B. Ludin et al.

    GFP illuminates the cytoskeleton

    Trends Cell Biol.

    (1998)
  • J.V. Small et al.

    Cytoskeleton cross-talk during cell motility

    FEBS Lett.

    (1999)
  • H. Daub et al.

    Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation at serine 16

    J. Biol. Chem.

    (2001)
  • T. Wittmann et al.

    Regulation of microtubule destabilizing activity of Op18/stathmin downstream of Rac1

    J. Biol. Chem.

    (2004)
  • K. Wong et al.

    Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway

    Cell

    (2001)
  • H. Fujita et al.

    Rapostlin is a novel effector of Rnd2 GTPase inducing neurite branching

    J. Biol. Chem.

    (2002)
  • S. Takahashi et al.

    Role for Fes/Fps tyrosine kinase in microtubule nucleation through is Fes/CIP4 homology domain

    J. Biol. Chem.

    (2003)
  • Cited by (49)

    • Fixing the GAP: The role of RhoGAPs in cancer

      2022, European Journal of Cell Biology
    • Rho GTPase-activating proteins: Regulators of Rho GTPase activity in neuronal development and CNS diseases

      2017, Molecular and Cellular Neuroscience
      Citation Excerpt :

      srGAP3 has also been demonstrated to be involved in the negative regulation of Rac1-dependent neurite outgrowth (Endris et al. 2011; Soderling et al. 2002; Zhang et al. 2014) by directly binding to WAVE-1 via its SH3 domain in vivo (Soderling et al. 2002). In addition to their roles in axon growth and guidance and neuronal migration, srGAPs, particularly srGAP3 and srGAP2, mediate cytoskeletal reorganization to regulate spine formation or synaptic maturation (Bacon et al. 2013; Charrier et al. 2012; Fossati et al. 2016; Yang et al. 2006). Fossati et al. have demonstrated that the ancestral srGAP2 (also referred to as srGAP2A) decreased the density of both excitatory and inhibitory synapses through its GAP activity (Fossati et al. 2016).

    • A link between the nuclear-localized srGAP3 and the SWI/SNF chromatin remodeler Brg1

      2014, Molecular and Cellular Neuroscience
      Citation Excerpt :

      Membrane-localized srGAP3 strongly inhibits cytoskeletal dynamics by acting at the interface between upstream guidance signals (e.g. Slit and its receptor robo1) and downstream key regulators of the actin machinery by down-regulation of Rac1 signaling (Bacon et al., 2012). Overexpression of srGAP3 in some neuroblastoma cells (Chen et al., 2011; Endris et al., 2011; Yang et al., 2006) and cerebellar granule neurons (Soderling et al., 2002) negatively regulates neurite outgrowth and neuronal differentiation. Although srGAP3 is present at the axon/dendrites, the protrusions and the cytoplasm, we observed that srGAP3 is predominantly expressed in the nucleus of cortical neurons (Fig. 4A) and Neuro2a cells (Fig. 5A).

    View all citing articles on Scopus
    1

    The first two authors contributed equally to the manuscript.

    View full text